ClinVar Miner

Submissions for variant NM_002470.4(MYH3):c.3731C>T (p.Ala1244Val)

gnomAD frequency: 0.00054  dbSNP: rs140074626
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000295438 SCV000400347 benign Freeman-Sheldon syndrome 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Illumina Laboratory Services, Illumina RCV000352771 SCV000400348 likely benign Distal arthrogryposis type 2B1 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000874040 SCV001016161 likely benign not provided 2025-01-27 criteria provided, single submitter clinical testing
GeneDx RCV000874040 SCV001940032 benign not provided 2020-09-01 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000874040 SCV004810995 likely benign not provided 2024-03-01 criteria provided, single submitter clinical testing MYH3: BP4
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV004800387 SCV005422875 uncertain significance not specified 2024-10-08 criteria provided, single submitter clinical testing Variant summary: MYH3 c.3731C>T (p.Ala1244Val) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0008 in 251474 control chromosomes, predominantly at a frequency of 0.0016 within the Non-Finnish European subpopulation in the gnomAD database, including 1 homozygote. To our knowledge, no occurrence of c.3731C>T in individuals affected with MYH3-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 321731). Based on the evidence outlined above, the variant was classified as VUS-possibly benign.
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV000874040 SCV001799158 likely benign not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000874040 SCV001927518 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.